Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Local Recurrence Due to Rectal Cancer in Sweden - the Actual Incidence, Treatment and Outcome After Treatment

NCT04404777 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.

NCT NCT04404777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04404777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Local Recurrence Due to Rectal Cancer in Sweden - the Actual Incidence, Treatment and Outcome After Treatment
Lead sponsor
Sahlgrenska University Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
July 1, 2022
Completion date
June 1, 2027
Enrollment
12,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal neoplasms